Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Xu-Welliver, M.
Right arrow Articles by Pegg, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu-Welliver, M.
Right arrow Articles by Pegg, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 5, 823-830, May 2002
© 2002 Oxford University Press


CARCINOGENESIS

Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase

Meng Xu-Welliver and Anthony E. Pegg,1

Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, PO Box 850, 500 University Drive, Hershey, PA 17033-0850, USA

O6-Alkylguanine-DNA alkyltransferase (AGT) is a DNA repair protein that removes alkyl groups from DNA by transferring them to an internal Cys-145 residue. As the S-alkylcysteine is not converted back to cysteine, the protein can only act once and the resulting alkylated AGT molecule is rapidly degraded. The mechanism underlying the disappearance of the alkylated AGT has been studied in vivo in CHO cells and in vitro in reticulocyte lysates by using the pseudosubstrate O6-benzylguanine (BG) and mutant forms of AGT. The wild-type AGT was stable but was ubiquitinated and degraded rapidly by the proteasome after treatment with BG or with an oligodeoxyribonucleotide, which contained O6-methylguanine. Mutants C145F (and other mutants with bulky substituents at position 145), which have alterations that cause a steric alteration at the active site and also prevent hydrogen bonding involving Cys-145 resembled the alkylated AGT and were ubiquitinated and degraded rapidly irrespective of treatment with BG. Mutant M134F, which causes a steric alteration without interfering directly with the hydrogen-bonding network involving Cys-145, partially destabilized AGT and its degradation was increased further by reaction with BG. Mutant C145S, which maintains the hydrogen-binding network and causes no distortion, was not rapidly degraded. The results indicate that the conformational change resulting in the opening of the asparagine hinge region in the structure, which is brought about by formation of an S-alkyl adduct, leads to an increased recognition by a ubiquitin ligase targeting the protein for degradation. This is a novel type of post-translational modification causing ubiquitination.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Guza, L. Ma, Q. Fang, A. E. Pegg, and N. Tretyakova
Cytosine Methylation Effects on the Repair of O6-Methylguanines within CG Dinucleotides
J. Biol. Chem., August 21, 2009; 284(34): 22601 - 22610.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. Remington, J. Chtchetinin, K. Ancheta, P. L. Nghiemphu, T. Cloughesy, and A. Lai
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity
Neuro-oncol, January 1, 2009; 11(1): 22 - 32.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
G. J. Kitange, B. L. Carlson, M. A. Schroeder, P. T. Grogan, J. D. Lamont, P. A. Decker, W. Wu, C. D. James, and J. N. Sarkaria
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Neuro-oncol, January 1, 2009; 11(3): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. J. Hansen, R. Nagasubramanian, S. M. Delaney, L. D. Samson, and M.E. Dolan
Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice
Carcinogenesis, May 1, 2007; 28(5): 1111 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Rasimas, S. R. Kar, A. E. Pegg, and M. G. Fried
Interactions of Human O6-Alkylguanine-DNA Alkyltransferase (AGT) with Short Single-stranded DNAs
J. Biol. Chem., February 2, 2007; 282(5): 3357 - 3366.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Tentori, C. Leonetti, M. Scarsella, A. Muzi, E. Mazzon, M. Vergati, O. Forini, R. Lapidus, W. Xu, A. S. Dorio, et al.
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma
FASEB J, August 1, 2006; 20(10): 1709 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Mijal, S. Kanugula, C. C. Vu, Q. Fang, A. E. Pegg, and L. A. Peterson
DNA Sequence Context Affects Repair of the Tobacco-Specific Adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by Human O6-Alkylguanine-DNA Alkyltransferases.
Cancer Res., May 1, 2006; 66(9): 4968 - 4974.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Keppler, H. Pick, C. Arrivoli, H. Vogel, and K. Johnsson
Labeling of fusion proteins with synthetic fluorophores in live cells
PNAS, July 6, 2004; 101(27): 9955 - 9959.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Liu, A. E. Pegg, K. M. Williams, and F. P. Guengerich
Paradoxical Enhancement of the Toxicity of 1,2-Dibromoethane by O6-Alkylguanine-DNA Alkyltransferase
J. Biol. Chem., September 27, 2002; 277(40): 37920 - 37928.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.